Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach
Academic Article
Publication Date:
2015
Abstract:
Stage IV non-small cell lung cancer (NSCLC) is characterized by poor prognosis. Palliative chemotherapy and/or best supportive care are considered standard treatment. Nevertheless, for patients with limited distant metastases (1-5 metastases), called oligometastatic disease, better prognosis has been observed. We evaluated response rate, survival, time to progression and toxicity in oligometastatic/oligorecurrent NSCLC patients treated with stereotactic body radiotherapy (SBRT) delivered to all active sites in the lung.
CRIS type:
1.1 Articolo in rivista
Keywords:
Stereotactic body radiotherapy; lung metastases; oligometastatic non-small lung cancer; Adenocarcinoma; Aged; Aged; 80 and over; Carcinoma; Non-Small-Cell Lung; Carcinoma; Squamous Cell; Disease Progression; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence; Local; Neoplasm Staging; Prognosis; Quality of Life; Remission Induction; Retrospective Studies; Survival Rate; Radiosurgery
List of contributors:
Agolli, Linda; Valeriani, Maurizio; Nicosia, Luca; Bracci, Stefano; De Sanctis, Vitaliana; Minniti, Giuseppe; Enrici, Riccardo Maurizi; Osti, Mattia Falchetto
Published in: